Form 4: Belite Bio Executive Sells Shares
Insider Transaction (Form 4)
Hendrik Peter Scholl, Chief Medical Officer of Belite Bio, Inc, sold 500 shares of common stock on October 1, 2026.
Summary
- Open-market sale: disposed of 200 American depositary share at $163.62 ($32,725) on October 1, 2026; holds 14,800 after (Indirect).
- Open-market sale: disposed of 24 American depositary share at $164.64 ($3,951) on October 1, 2026; holds 14,776 after (Indirect).
- Open-market sale: disposed of 120 American depositary share at $165.49 ($19,859) on October 1, 2026; holds 14,656 after (Indirect).
- Open-market sale: disposed of 50 American depositary share at $166.44 ($8,322) on October 1, 2026; holds 14,606 after (Indirect).
- Open-market sale: disposed of 78 American depositary share at $167.59 ($13,072) on October 1, 2026; holds 14,528 after (Indirect).
- Open-market sale: disposed of 12 American depositary share at $168.21 ($2,019) on October 1, 2026; holds 14,516 after (Indirect).
- Open-market sale: disposed of 14 American depositary share at $169.36 ($2,371) on October 1, 2026; holds 14,502 after (Indirect).
- Open-market sale: disposed of 2 American depositary share at $170.02 ($340) on October 1, 2026; holds 14,500 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $82,659 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Hendrik Peter Scholl — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | American depositary share | 200 | $164 | $32.7K | 14,800 |
| 2026-10-01 | Open-market sale | American depositary share | 24 | $165 | $4.0K | 14,776 |
| 2026-10-01 | Open-market sale | American depositary share | 120 | $165 | $19.9K | 14,656 |
| 2026-10-01 | Open-market sale | American depositary share | 50 | $166 | $8.3K | 14,606 |
| 2026-10-01 | Open-market sale | American depositary share | 78 | $168 | $13.1K | 14,528 |
| 2026-10-01 | Open-market sale | American depositary share | 12 | $168 | $2.0K | 14,516 |
| 2026-10-01 | Open-market sale | American depositary share | 14 | $169 | $2.4K | 14,502 |
| 2026-10-01 | Open-market sale | American depositary share | 2 | $170 | $340 | 14,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (200 shares) |
| 2026-10-01 | Open-market sale (24 shares) |
| 2026-10-01 | Open-market sale (120 shares) |
| 2026-10-01 | Open-market sale (50 shares) |
| 2026-10-01 | Open-market sale (78 shares) |
| 2026-10-01 | Open-market sale (12 shares) |
| 2026-10-01 | Open-market sale (14 shares) |
| 2026-10-01 | Open-market sale (2 shares) |
Keywords
insider transaction, Form 4, BLTE, BELITE BIO, INC, bearish, Hendrik Peter Scholl
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.